Shree Bhagat Kisan Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.70 M
as on 12-12-2024
- Paid Up Capital ₹ 5.67 M
as on 12-12-2024
- Company Age 19 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
About Shree Bhagat Kisan Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.70 M and a paid-up capital of Rs 5.67 M, as per Ministry of Corporate Affairs (MCA) records.
Parvati Devi and Krishna Kumari serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC157151
- Company No.
157151
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Bhagat Kisan Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parvati Devi  | Director | 15-Feb-2024 | Current |
| Krishna Kumari | Director | 30-Dec-2010 | Current |
Financial Performance of Shree Bhagat Kisan Biotech.
Shree Bhagat Kisan Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shree Bhagat Kisan Biotech?
In 2017, Shree Bhagat Kisan Biotech had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jharkhand Organic Farms Private LimitedActive 19 years 28 daysParvati Devi and Krishna Kumari are mutual person
- Vananchal Infrastructures Private LimitedActive 21 years 5 months
Parvati Devi and Krishna Kumari are mutual person
- Vananchal Farms & Horticulture Private LimitedActive 21 years 3 months
Parvati Devi and Krishna Kumari are mutual person
- Parvti Buildcon Private LimitedActive 19 years 15 days
Parvati Devi and Krishna Kumari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shree Bhagat Kisan Biotech?
Unlock and access historical data on people associated with Shree Bhagat Kisan Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Bhagat Kisan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Bhagat Kisan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
